Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Hyperphosphatemia
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Treatment== High phosphate levels can be avoided with [[phosphate binders]] and dietary restriction of phosphate.<ref name="Merck Manual Hyperphos" /> If the kidneys are operating normally, a saline diuresis can be induced to renally eliminate the excess phosphate. In extreme cases, the blood can be filtered in a process called [[hemodialysis]], removing the excess phosphate.<ref name="Merck Manual Hyperphos" /> Phosphate-binding medications include [[sevelamer]], [[lanthanum carbonate]], [[calcium carbonate]], and [[calcium acetate]].<ref>{{Cite book|title=Critical care nursing : diagnosis and management|date=2014|publisher=Elsevier/Mosby|others=Urden, Linda Diann.|isbn=978-0-323-09178-7|edition=7th|location=St. Louis, Mo.|pages=716|oclc=830669119}}</ref> Previously [[Aluminium hydroxide|aluminum hydroxide]] was the medication of choice, but its use has been largely abandoned due to the increased risk of [[Aluminium toxicity in people on dialysis|aluminum toxicity]].<ref>{{Cite journal|last1=Hutchison|first1=Alastair J.|last2=Smith|first2=Craig P.|last3=Brenchley|first3=Paul E. C.|date=October 2011|title=Pharmacology, efficacy and safety of oral phosphate binders|url=http://www.nature.com/articles/nrneph.2011.112|journal=Nature Reviews Nephrology|language=en|volume=7|issue=10|pages=578β589|doi=10.1038/nrneph.2011.112|pmid=21894188|s2cid=19833271|issn=1759-5061|url-access=subscription}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)